The compromised osteogenic capacity of BMSCs and the heightened osteoclastogenic propensity of osteoclast precursor cells sourced from untreated OI mice, in comparison to the respective cells from wild-type mice, were both mitigated through the application of DKK1-AS. Here, DKK1 is linked to osteogenesis imperfecta.